Cámara-Quílez, M.; Barreiro-Alonso, A.; Vizoso-Vázquez, Á.; Rodríguez-Belmonte, E.; Quindós-Varela, M.; Lamas-Maceiras, M.; Cerdán, M.E.
The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response. Cancers 2020, 12, 2435.
https://doi.org/10.3390/cancers12092435
AMA Style
Cámara-Quílez M, Barreiro-Alonso A, Vizoso-Vázquez Á, Rodríguez-Belmonte E, Quindós-Varela M, Lamas-Maceiras M, Cerdán ME.
The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response. Cancers. 2020; 12(9):2435.
https://doi.org/10.3390/cancers12092435
Chicago/Turabian Style
Cámara-Quílez, María, Aida Barreiro-Alonso, Ángel Vizoso-Vázquez, Esther Rodríguez-Belmonte, María Quindós-Varela, Mónica Lamas-Maceiras, and María Esperanza Cerdán.
2020. "The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response" Cancers 12, no. 9: 2435.
https://doi.org/10.3390/cancers12092435
APA Style
Cámara-Quílez, M., Barreiro-Alonso, A., Vizoso-Vázquez, Á., Rodríguez-Belmonte, E., Quindós-Varela, M., Lamas-Maceiras, M., & Cerdán, M. E.
(2020). The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response. Cancers, 12(9), 2435.
https://doi.org/10.3390/cancers12092435